Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methadone versus methadone plus Acceptance and Commitment Therapy for relapse prevention in opioid use disorder
IRCT2016062328603N1Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Jul 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of methadone in opioid use disorder (OUD) (2 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoint: Relapse rate. Started Jul 2016; status: completed.
02
Drugs
methadone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on IRCT2016062328603N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016062328603N1.